share_log
Reuters ·  17:56
Innovent Biologics Inc - Lilly to Manage R&D and Post-Market Medical Affairs for Jaypirca
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment